NCT/Study#
NCT03915951 /
ARRAY-818-202
A Phase 2, Open-Label Study Of Encorafenib + Binimetinib In Patients With BRAFV600E-Mutant Non-Small Cell Lung Cancer
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
